A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)
Part of paid clinical trials in Carlsbad, California.
- Sponsor
- Boston Scientific Corporation
- Study ID
- NCT04192591
- Status
- Active Not Recruiting
Conditions
- Lumbar Spinal Stenosis
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Superion™ IDS device — DEVICEThe Superion™ IDS is a minimally-invasive spinal implant that treats LSS symptoms by limiting extension at the symptomatic level that compresses the neural elements and is designed for percutaneous surgical placement.
Study Details
To compile real-world outcomes of the Superion™ IDS in routine clinical practice.
Key Dates
- First listed
- Dec 10, 2019
- Start date
- Jan 30, 2020
- Status verified
- Aug 2026
- Primary completion
- Feb 28, 2038
- Completion
- Feb 28, 2041
Study Design
- Enrollment
- 166 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Superion™ IDS deviceSuperion™ Indirect Decompression System (IDS)
Primary Outcome Measure
Rate of success at the 24-month follow-up visit [ Time Frame: 24-Months ]
Locations (23)
Find similar trials in Carlsbad, CA
Related Studies
- MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims StudyRecruiting · Stryker Instruments · Athens, Alabama
- Study Comparing Local/ MAC Anesthesia in Lumbar DecompressionEARLY_PHASE1 · Recruiting · Stanford University · Redwood City, California
- Regional Anesthesia in Minimally Invasive Lumbar Spine SurgeryPHASE4 · Recruiting · John O'Toole · Chicago, Illinois
- Lumbar Steroid Use in Patients Undergoing Posterior Lumbar DecompressionPHASE3 · Recruiting · Hospital for Special Surgery, New York · New York, New York